Table 2 Clinical patient outcomes
Characteristic | UAE-SCE group (n = 16) | UAE-FCE group (n = 8) | p value |
|---|---|---|---|
Post-procedural serum β-hCG level (mIU/mL) | 9296.08 ± 2425.87 | 8921.17 ± 4182.38 | 0.740 |
Time for β-hCG normalization (days) | 28.94 ± 1.41 | 27.88 ± 1.86 | 0.574 |
Side effects | |||
Pelvic pain (n) | 3 | 1 | 0.705 |
Amount of blood loss (mL) | 78.75 ± 26.63 | 712.50 ± 110.91 | 0.025 |
Anemia (n) | 0 | 3 | 0.01 |